Gunnar Brobert

7PUBLICATIONS
22CO-AUTHORS
PharmacogenomicsAutonomic nervous systemElectrical energy generation (incl. renewables, excl. photovoltaics)Cardiology (incl. cardiovascular diseases)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 26, 2024
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.

Gunnar Brobert, Ana Ruigomez, Tania Schink

|Feb 16, 2023
Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.

Luis Alberto García Rodríguez, Ana Ruigómez, Tania Schink

|Feb 01, 2023
Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands.

Annemarie Voss, Elisabeth Smits, Karin M A Swart

|Nov 09, 2022
Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom.

Antonio González-Pérez, Yanina Balabanova, María E Sáez

|Jun 10, 2022
Time Trends and Treatment Pathways in Prescribing Individual Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: An Observational Study of More than Three Million Patients from Europe and the United States.

Pareen Vora, Henry Morgan Stewart, Beth Russell

|Oct 03, 2020
Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network.

Ana Ruigómez, Gunnar Brobert, Pareen Vora

Pageof 2

Frequent Collaborators

5 joint publications

Luis Alberto García-Rodríguez

5 joint publications

Yanina Balabanova

4 joint publications

Tania Schink

4 joint publications

Ron M C Herings